You can never do enough due diligence.
The company plans to reinvest savings of the restructuring program into strategic growth initiatives.
A roundtable discussion on key issues that medtech companies face in product development.
As industry reels from new regulations, margins are razor thin. The top priority is to build creative solutions to improve the bottom line.
A strategy that pulls in regulatory, quality, clinical, reimbursement, marketing, compliance, legal and finance is required.
Device companies can tap into a growing market that needs more cost effective healthcare services.
Consider taking a multi-pronged approach to this complex landscape.
The union of the two companies creates a market opportunity of nearly $30 billion.
The strong demand for telemedicine services presents significant opportunities.
Today’s business operations environment demands faster, more tangible returns.